New Wave Biotech Secures €1.2 Million in Latest Funding Round to Expand AI Bioprocess Simulation Platform

New Wave Biotech, a company specializing in AI-driven bioprocess simulation software, has secured €1.2 million in funding from Innovate UK and EIT Food. The investment will support the company in expanding its team and customer base, with a focus on optimizing biomanufacturing processes using artificial intelligence. The primary product, the Bioprocess Foresight platform, allows companies in the synthetic biology sector to predict outputs, costs, and environmental impacts before physical experiments.

The funding comes at a crucial time for the synthetic biology industry, as scaling production remains a challenge. New Wave Biotech's platform aims to reduce the time and cost associated with R&D in biomanufacturing, providing a virtual testing environment for designing, commercializing, and scaling new products more efficiently. With the new capital, the company plans to further extend the reach of its platform for broader applications in synthetic biology and alternative protein production, advancing its mission to accelerate these technologies from lab to market.